| Trial ID: | L3800 |
| Source ID: | NCT02802644
|
| Associated Drug: |
Sitagliptin
|
| Title: |
The Effect of DPP4 Inhibitor on Vasclular Healing
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Acute Coronary Syndrome|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Sitagliptin|DRUG: Non DPP-4 Inhibitor
|
| Outcome Measures: |
Primary: Neointimal coverage assessed by optical coherence tomography, 6 months | Secondary: Malapposition, neointimal thickness or any optical coherence tomographic finding, 6 months|Biomarkers, CD 34+ cell, hs CRP ect., 6 months
|
| Sponsor/Collaborators: |
Sponsor: Chung-Ang University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
66
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2016-06
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2016-06-16
|
| Locations: |
Keimyung University Hospital, Daegu, Korea, Republic of|Chonnam National University Hospital, Gwangju, Korea, Republic of|Jeju National University Hospital, Jeju, Korea, Republic of|Chung-Ang University Hospital, Seoul, 06973, Korea, Republic of|Korea University Guro Hospital, Seoul, Korea, Republic of|Ajou University Hospital, Suwon, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02802644
|
